Unethical Advertising
14) http://abcnews.go.com/Health/story?id=117868&page=1#.UXHHzzdaZac
FDA to Examine Hepatitis C Campaign
W A S H I N G T O N, Sept. 14
(ad image of bruised face)
15) http://amarillo.com/stories/111200/tex_healthoff.shtml
Roche Launches New Campaign to Educate Consumers About Hepatitis C
NUTLEY, New Jersey (July 26, 2005) -- Roche announced today the launch of
a major new campaign to motivate hepatitis C patients who have been
diagnosed with the disease to take the critical step of discussing
prescription treatment with a liver specialist or hepatitis C-treating
physician.
16) http://www.natap.org/2005/HCV/072905_01.htm
Health officials demand changes in hepatitis C ads
Posted: Sunday, November 12, 2000
17) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC172879/
Clin Microbiol Rev. 1996 January; 9(1): 18--33.
Sequence-based identification of microbial pathogens: a reconsideration
of Koch's postulates.D N Fredericks and D A Relman Department of
Medicine, Stanford University School of Medicine, California 94305,
USA. Over 100 years ago, Robert Koch introduced his ideas about how to
prove a causal relationship between a microorganism and a disease.
Koch's postulates created a scientific standard for causal evidence that
established the credibility of microbes as pathogens and led to the
development of modern microbiology. In more recent times, Koch's
postulates have evolved to accommodate a broader understanding of the
host-parasite relationship as well as experimental advances. Techniques
such as in situ hybridization, PCR, and representational difference
analysis reveal previously uncharacterized, fastidious or uncultivated,
microbial pathogens that resist the application of Koch's original
postulates, but they also provide new approaches for proving disease
causation. In particular, the increasing reliance on sequence-based methods for microbial identification requires a reassessment of the original postulates and
the rationale that guided Koch and later revisionists.
18) http://www.ncbi.nlm.nih.gov/pubmed/22731712
Ann N Y Acad Sci. 2012 Jul;1258:25-33.
Zonulin, regulation of tight junctions, and autoimmune diseases. Fasano
A. Mucosal Biology Research Center and Center for Celiac Research,
University of Maryland School of Medicine, Baltimore, Maryland, USA.
19) http://www.townsendletter.com/Dec2007/alphalipo1207.htm
Alpha Lipoic Acid and Liver Disease
by Burton M. Berkson, MD, MS, PhD
20) http://www.ncbi.nlm.nih.gov/pubmed/10554539
Med Klin (Munich). 1999 Oct 15;94 Suppl 3:84-9.
A conservative triple antioxidant approach to the treatment of hepatitis
C. Combination of alpha lipoic acid (thioctic acid), silymarin, and
selenium: three case histories. Berkson BM. Integrative Medical Center
of New Mexico, New Mexico State University, Las Cruces, USA.
21) http://www.ncbi.nlm.nih.gov/pubmed/11910339
Gastroenterology. 2002 Apr;122(4):881-8.
Celiac disease in patients with severe liver disease: gluten-free diet
may reverse hepatic failure. Kaukinen K, Halme L, Collin P, Fà ¤rkkilà ¤ M,
MÃ ¤ki M, Vehmanen P, Partanen J, HÃ ¶ckerstedt K. Department of Internal
Medicine, Tampere University Hospital, Tampere, Finland.
Jeffrey Dach MD
Link to this article:http://wp.me/p3gFbV-gd
Copyright (c) 2013 Jeffrey Dach MD All Rights Reserved. This article may be reproduced on the internet without permission, provided there is a link to this page and proper credit is given.
FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a "fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).